tirelizumab
Showing 1 - 8 of 8
PFS Trial (Decitabine Injection, tirelizumab)
Not yet recruiting
- PFS
- Decitabine Injection
- tirelizumab
- (no location specified)
Nov 24, 2022
TNBC - Triple-Negative Breast Cancer Trial in Wuhan (Utidelone, Tirelizumab, Bevacizumab)
Recruiting
- TNBC - Triple-Negative Breast Cancer
- Utidelone
- +2 more
-
Wuhan, Hubei, ChinaTongji Hospital Affiliated of Tongji Medical College Huazhong Un
Nov 5, 2023
Gastric Cancer Trial in Yixing (tirelizumab, chemo with oxaliplatin + heroda)
Recruiting
- Gastric Cancer
- tirelizumab
- chemotherapy with oxaliplatin + heroda
-
Yixing, Jiangsu, ChinaYixing People's Hospital
May 3, 2023
Nasopharyngeal Carcinoma Trial (Tirelizumab, salvage surgery)
Not yet recruiting
- Nasopharyngeal Carcinoma
- Tirelizumab
- salvage surgery
- (no location specified)
Oct 22, 2021
Stomach Cancer Trial (Tirelizumab, Trastuzumab, Docetaxel)
Not yet recruiting
- Stomach Cancer
- Tirelizumab
- +4 more
- (no location specified)
Aug 19, 2021
Esophageal Squamous Cell Carcinoma Trial in Shanghai (Tirelizumab, Nab paclitaxel, Carboplatin)
Recruiting
- Esophageal Squamous Cell Carcinoma
- Tirelizumab
- +3 more
-
Shanghai, Shanghai, ChinaRuijin hospital, Shanghai jiaotong university school of medicine
Nov 6, 2023
Esophageal Squamous Cell Carcinoma Trial in Chengdu (Tirelizumab, Paclitaxel, Carboplatin)
Recruiting
- Esophageal Squamous Cell Carcinoma
- Tirelizumab
- +3 more
-
Chengdu, Sichuan, ChinaSichuan Cancer Hospital and Research Institute
Feb 8, 2022
Immunotherapy, Adjuvant Therapy, Colon Cancer Trial in Tianjin (Tirelizumab)
Recruiting
- Immunotherapy
- +3 more
- Tirelizumab
-
Tianjin, ChinaTianjin Medical University Cancer Institute and Hospital
Jul 11, 2021